Key result
Arg723His mutation in β-MYH7 linked to HCM by disrupting critical non-covalent protein interactions.
Why the study?
Mutations in the beta-MYH7 gene cause cardiomyopathies, but differentiating a causative nsSNP and determining its impact on protein structure remains a major challenge.
Observational (n=208)
The identification of the pathogenic R723H mutation in β-MYH7 and its structural impact provides insights into HCM pathogenesis and potential targets for myosin modulators.
Mutations in the β-MYH7 gene are one of the major causes that lead to cardiomyopathies. However, to differentiate a causative nsSNP and its impact on protein structure remains a major challenge. In the present study, we detected a missense mutation Arg723His in the head motor domain of β-MYH7 in a HCM patient, and it was absent in 207 healthy individuals. The mutant (R723H) has been found to alter an evolutionarily conserved amino acid. In addition, the mutant (R723H) was predicted pathogenic by Polyphen-2 and SIFT bioinformatic tools. Further, the superimposed 3D structure of the mutant (p.His723 homology model) with native (p. Arg723) displayed the root means square deviation (RMSD) of ~3.38A0. We know that the non-covalent interactions such as hydrophobic, electrostatic, Van der Waals, and hydrogen bonds between amino acids are at the heart of stabilizing protein structures. Here, we demonstrated how the mutant (p.His723) has disrupted a critical non-covalent interactions network at the mutation site and may contribute to the disease phenotype. Hence, our findings in the future could pave the way for developing small molecular modulators or myosin-targeted therapies for heart failure.
No takes yet. Share an insight, caveat, or question.
Rani et al. (2021) conducted an observational in Hypertrophic cardiomyopathy (HCM) (n=208). Arg723His missense mutation in β-MYH7 vs. Native p.Arg723 / Healthy individuals was evaluated on Protein structure disruption and pathogenicity. The Arg723His missense mutation in the β-MYH7 gene, found in an Indian HCM patient but absent in 207 healthy controls, disrupted critical non-covalent interactions with an RMSD of ~3.38A0.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: